Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore [NA]
A completed clinical trial evaluated whether achieving early target trough levels of tacrolimus using CYP3A5-guided dosing provides advantag…
-
FDA approval · 2024-11-07FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Wuxi Fortune Pharmaceutical Co.,Ltd.)
The FDA approved the original application for a generic mycophenolate mofetil formulation from Wuxi Fortune Pharmaceutical Co., Ltd.
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Observational Cohort Study Renal Transplantation University Hospitals Leuven
This entry describes an observational cohort study on renal transplantation conducted by University Hospitals Leuven; the trial is currently…
-
FDA approval · 2024-10-22FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for a generic mycophenolate mofetil product.
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Clinical Impact of the IBox As an Early Intervention TooL [NA]
An update on the clinical impact of the IBox early intervention tool for kidney-related conditions; the study is currently active but not re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
A clinical trial update announcing ongoing recruitment to expand post-transplant detection and monitoring of HLA-specific antibodies in rena…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's supplemental application for generic Mycophenolate mofetil. The approval supports continued use for prevent…
-
FDA label_change · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Mycophenolate mofetil from Endo USA, Inc., updating the drug's labeling.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Aurobindo Pharma Limited, allowing the generic product for use in pre…
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil hydrochloride) submitted by Genentech to update the label.
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for CellCept (mycophenolate mofetil) submitted by Genentech, Inc.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Mycophenolate mofetil from Meitheal Pharmaceuticals Inc., confirming the generic product's appro…
-
FDA approval · 2024-08-13FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved Genentech's supplemental application for CELLCEPT (mycophenolate mofetil), resulting in an approved update to the product label…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Lannett Company, authorizing a generic version under ANDA 214525.
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil from Concord Biotech Limited under ANDA 212087.
-
FDA approval · 2024-08-09FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s mycophenolate mofetil under an ANDA. The approval updates the generic p…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
An observational registry (ProActive) sponsored by Natera to assess active rejection in kidney transplant recipients as part of the PROspera…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: BIOtechnology Applied to Renal TRansplantation With IMmunobiogram
Completed clinical trial evaluating biotechnology applied to renal transplantation using Immunobiogram for kidney transplant failure and rej…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Impact of Microvascular Inflammation on Kidney Allograft Outcome
Completed clinical trial update assessing the impact of microvascular inflammation on kidney allograft outcomes.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing tacrolimus extended-release (Envarsus XR) to immediate-release tacrolimus in HLA-sensitized kidney transplant recipi…
-
CLINICAL_TRIALS withdrawal · 2024-06-07Clinical Trial Update: Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants [Phase 2]
A Phase 2 clinical trial evaluating cellular immunotherapy for immune tolerance in past recipients of HLA zero-mismatch, living-donor kidney…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants [Phase 3]
Phase 3 trial evaluating cellular immunotherapy in recipients of HLA-matched living-donor kidney transplants has completed.
-
CLINICAL_TRIALS withdrawal · 2024-06-07Clinical Trial Update: Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants [Phase 2, Phase 3]
The Phase 2/3 study of cellular immunotherapy in HLA-mismatched living donor kidney transplant recipients has been withdrawn.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection [NA]
A clinical trial evaluating the immunosuppressant everolimus for kidney transplant patients with NK-mediated rejection is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN
The EU-TRAIN study on precision risk stratification in kidney transplant patients has completed.